You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Litigation Details for Finjan, Inc. v. Qualys Inc. (N.D. Cal. 2018)

✉ Email this page to a colleague

« Back to Dashboard

Finjan, Inc. v. Qualys Inc. (N.D. Cal. 2018)

Docket	⤷ Try a Trial	Date Filed	2018-11-29
Court	District Court, N.D. California	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Yvonne Gonzalez Rogers
Jury Demand	Both	Referred To
Parties	FINJAN, INC.; QUALYS INC.
Patents	10,154,990; 10,183,968; 10,183,975; 10,231,964; 10,231,975; 10,231,983; 10,239,954; 10,246,708; 10,266,822; 10,278,974; 10,327,926; 10,331,349; 10,335,388; 10,335,390; 10,335,391; 10,335,397; 10,335,420; 10,335,494; 10,363,320; 10,369,409; 10,370,414; 10,375,964; 10,377,731; 10,379,975; 10,383,344; 10,383,357; 10,383,954; 10,385,399; 10,386,359; 10,386,366; 10,386,376; 10,391,154; 10,392,349; 10,392,357; 10,392,406; 10,392,413; 10,401,371; 10,406,332; 10,406,383; 10,407,393; 10,421,954; 10,494,413; 10,494,414; 10,633,423; 6,183,974; 6,335,369; 6,355,415; 6,355,425; 6,387,383; 6,406,387; 6,406,731; 6,420,322; 6,423,319; 6,613,357; 6,844,390; 6,893,253; 6,893,633; 6,893,639; 6,919,341; 6,919,348; 6,919,392; 6,923,968; 6,962,151; 6,974,893; 7,270,968; 7,305,986; 7,320,968; 7,338,968; 7,348,319; 7,354,416; 7,358,393; 7,358,402; 7,361,650; 7,364,752; 7,371,408; 7,371,409; 7,377,866; 7,378,418; 7,378,423; 7,384,354; 7,384,650; 7,392,398; 7,392,844; 7,396,341; 7,396,822; 7,416,752; 7,422,388; 7,423,391; 7,425,326; 7,425,333; 7,494,815; 7,520,866; 7,731,986; 7,772,462; 7,893,287; 7,919,322; 7,964,183; 7,964,219; 7,964,357; 7,964,359; 7,964,402; 7,964,647; 7,968,263; 7,968,302; 7,968,351; 7,968,735; 8,008,006; 8,236,975; 8,277,822; 8,323,677; 8,327,844; 8,329,419; 8,329,752; 8,333,974; 8,334,413; 8,338,376; 8,338,385; 8,338,395; 8,338,408; 8,349,321; 8,354,409; 8,357,369; 8,357,375; 8,357,394; 8,357,677; 8,367,402; 8,367,415; 8,372,396; 8,372,968; 8,377,919; 8,383,359; 8,383,417; 8,387,351; 8,388,954; 8,394,367; 8,394,372; 8,394,377; 8,394,387; 8,394,405; 8,394,406; 8,394,407; 8,399,396; 8,415,337; 8,415,345; 8,415,348; 8,415,355; 8,415,363; 8,415,382; 8,415,393; 8,415,396; 8,420,650; 8,425,353; 8,591,983; 8,613,965; 8,647,639; 8,752,419; 8,822,407; 8,822,423; 8,926,493; 8,962,593; 8,962,630; 8,962,804; 8,975,382; 8,980,885; 9,227,983; 9,265,893; 9,271,866; 9,271,968; 9,285,364; 9,285,372; 9,326,974; 9,334,320; 9,345,677; 9,351,975; 9,353,366; 9,353,368; 9,353,371; 9,358,338; 9,359,367; 9,363,752; 9,371,377; 9,371,392; 9,371,393; 9,375,412; 9,375,494; 9,376,366; 9,381,305; 9,381,416; 9,382,321; 9,383,349; 9,383,370; 9,386,990; 9,387,360; 9,387,383; 9,388,425; 9,393,305; 9,393,351; 9,393,372; 9,394,344; 9,395,364; 9,402,919; 9,408,393; 9,408,893; 9,410,954; 9,416,366; 9,416,367; 9,416,371; 9,421,351; 9,422,335; 9,630,930; 9,650,393; 9,650,395; 9,650,416; 9,708,397; 9,822,351; 9,879,267; 9,974,302; 9,974,839; 9,975,919; 9,983,185
Attorneys	Christopher Don Mays; Edward G. Poplawski; James R. Hannah; Lisa Kobialka; Olivia M Kim; Paul J. Andre; Ryan R. Smith
Firms	Kramer Levin Naftalis & Frankel LLP; Wilson Sonsini Goodrich & Rosati; Wilson Sonsini Goodrich & Rosati, P.C.; Wilson Sonsini Goodrich and Rosati
Link to Docket	External link to docket

Small Molecule Drugs cited in Finjan, Inc. v. Qualys Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Biologic Drugs cited in Finjan, Inc. v. Qualys Inc.

The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Details for Finjan, Inc. v. Qualys Inc. (N.D. Cal. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2020-03-14	50	Opposition/Response to Motion	,975,305 (“’305 Patent”) to allege that Finjan should be precluded 8 from asserting different claims…on Finjan’s patent license to Trend Micro (the “Agreement”). 7 Under the Agreement, 8 9 10 11…motion for leave to assert patent exhaustion and implied 7 license defenses. 8 2. …Martin Corp. v. Network Sols., Inc., 194 F.3d 980 (9th Cir. 1999) .................................…Martin Corp. v. Network 15 Sols., Inc., 194 F.3d 980, 986 (9th Cir. 1999). 16 Qualys alleges	External link to document
2020-03-16	52	Response ( Non Motion )	, 944 9 F.3d at 907; Poly-America, 839 F.3d at 1136. 10 Dkt. 42-5 ‘968 patent at Figure… 907; Poly-America, 839 F.3d at 18 1136. Judge Alsup also noted that the Patent Office similarly interpreted… ’154 patent (1-2, 6-7) 9 Transmitter ’968 patent (6) 10 …. 42-2 ’494 patent at 22:9; Dkt. 42-4 ’154 patent at 17:48-49, 18:17-18, 18:26-27; 3 Rubin Decl. ¶…53; Rubin Decl. at ¶ 49. 9 ’494 Patent. Claim 10 of the ’494 Patent states that the receiver	External link to document
2020-04-13	60	Exhibit F	90071 Telephone: (323) 210-2901 6 Facsimile: (866) 974-7329 7 RYAN R. SMITH (SBN 229323… a processor that ‘154 Patent: Abstract; Claims 1, 6; Figs. 1-5; 2:64-67; 3:1-67; 4:15-26… 6 QUALYS’S PATENT L.R. 4-2 DISCLOSURES … ’408 Patent: Abstract; Claims 1, 8, 9, 22; Figs. 1, 2, 5, 6, 7; 1:59-2:65; 3:22-45;… ’154 Patent: Figs. 2-5; 6:60-65, 8:54-60, 15:26-29; claims 1-3	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.